You just read:

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

News provided by

NeoGenomics, Inc.

27 Apr, 2016, 07:00 ET